These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 35269629)
1. Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration. Romaus-Sanjurjo D; Regueiro U; López-López M; Vázquez-Vázquez L; Ouro A; Lema I; Sobrino T Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269629 [TBL] [Abstract][Full Text] [Related]
2. Ocular indicators of Alzheimer's: exploring disease in the retina. Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291 [TBL] [Abstract][Full Text] [Related]
3. Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease. Singh AK; Verma S Indian J Ophthalmol; 2020 Apr; 68(4):555-561. PubMed ID: 32174567 [TBL] [Abstract][Full Text] [Related]
5. [THE RETINA AS A TOOL FOR EARLY DIAGNOSIS OF ALZHEIMER DISEASE]. Wood K; Maharshak I; Koronyo Y; Koronyo-Hamaoui M Harefuah; 2022 Aug; 161(8):523-525. PubMed ID: 35979573 [TBL] [Abstract][Full Text] [Related]
6. Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor. Wright LM; Stein TD; Jun G; Chung J; McConnell K; Fiorello M; Siegel N; Ness S; Xia W; Turner KL; Subramanian ML J Alzheimers Dis; 2019; 68(4):1429-1438. PubMed ID: 30856114 [TBL] [Abstract][Full Text] [Related]
7. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Prvulovic D; Hampel H Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022 [TBL] [Abstract][Full Text] [Related]
8. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer's disease in the 3xTg-AD mouse model. Grimaldi A; Brighi C; Peruzzi G; Ragozzino D; Bonanni V; Limatola C; Ruocco G; Di Angelantonio S Cell Death Dis; 2018 Jun; 9(6):685. PubMed ID: 29880901 [TBL] [Abstract][Full Text] [Related]
9. Ocular Biomarkers in Alzheimer's Disease: Insights into Early Detection Through Eye-Based Diagnostics - A Literature Review. Firmani G; Salducci M; Testa F; Covelli GP; Sagnelli P; Lambiase A Clin Ter; 2024; 175(5):352-361. PubMed ID: 39400101 [TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567 [TBL] [Abstract][Full Text] [Related]
11. [Potential biomarkers of early diagnosis of Alzheimer's disease]. Bogolepova AN; Makhnovich EV; Kovalenko EA; Osinovskaya NA Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):7-14. PubMed ID: 36168682 [TBL] [Abstract][Full Text] [Related]
12. Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions. Dehghani C; Frost S; Jayasena R; Masters CL; Kanagasingam Y Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3554-3563. PubMed ID: 30025102 [TBL] [Abstract][Full Text] [Related]
13. Ocular biomarkers of Alzheimer's disease. Heaton GR; Davis BM; Turner LA; Cordeiro MF Cent Nerv Syst Agents Med Chem; 2015; 15(2):117-25. PubMed ID: 25788142 [TBL] [Abstract][Full Text] [Related]
15. Exercise to Counteract Alzheimer's Disease: What Do Fluid Biomarkers Say? Bonanni R; Cariati I; Cifelli P; Frank C; Annino G; Tancredi V; D'Arcangelo G Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000060 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979 [TBL] [Abstract][Full Text] [Related]
17. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease. Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322 [TBL] [Abstract][Full Text] [Related]
18. Biological markers of Alzheimer's disease. de Souza LC; Sarazin M; Teixeira-Júnior AL; Caramelli P; Santos AE; Dubois B Arq Neuropsiquiatr; 2014 Mar; 72(3):227-31. PubMed ID: 24676441 [TBL] [Abstract][Full Text] [Related]
19. New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer's disease. Park SA; Han SM; Kim CE Exp Mol Med; 2020 Apr; 52(4):556-568. PubMed ID: 32284537 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease pathophysiology in the Retina. Gaire BP; Koronyo Y; Fuchs DT; Shi H; Rentsendorj A; Danziger R; Vit JP; Mirzaei N; Doustar J; Sheyn J; Hampel H; Vergallo A; Davis MR; Jallow O; Baldacci F; Verdooner SR; Barron E; Mirzaei M; Gupta VK; Graham SL; Tayebi M; Carare RO; Sadun AA; Miller CA; Dumitrascu OM; Lahiri S; Gao L; Black KL; Koronyo-Hamaoui M Prog Retin Eye Res; 2024 Jul; 101():101273. PubMed ID: 38759947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]